A citation-based method for searching scientific literature

Zsofia Sztupinszki, Miklos Diossy, Marcin Krzystanek, Lilla Reiniger, István Csabai, Francesco Favero, Nicolai J Birkbak, Aron C Eklund, Ali Syed, Zoltan Szallasi. NPJ Breast Cancer 2018
Times Cited: 66



Isabelle Ray-Coquard, Patricia Pautier, Sandro Pignata, David Pérol, Antonio González-Martín, Regina Berger, Keiichi Fujiwara, Ignace Vergote, Nicoletta Colombo, Johanna Mäenpää, Frédéric Selle, Jalid Sehouli, Domenica Lorusso, Eva M Guerra Alía, Alexander Reinthaller, Shoji Nagao, Claudia Lefeuvre-Plesse, Ulrich Canzler, Giovanni Scambia, Alain Lortholary, Frederik Marmé, Pierre Combe, Nikolaus de Gregorio, Manuel Rodrigues, Paul Buderath, Coraline Dubot, Alexander Burges, Benoît You, Eric Pujade-Lauraine, Philipp Harter. N Engl J Med 2019
Times Cited: 509




List of shared articles



Times cited

Comparative Assessment of Diagnostic Homologous Recombination Deficiency-Associated Mutational Signatures in Ovarian Cancer.
Zsofia Sztupinszki, Miklos Diossy, Judit Borcsok, Aurel Prosz, Nanna Cornelius, Maj K Kjeldsen, Mansoor R Mirza, Zoltan Szallasi. Clin Cancer Res 2021
3

Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma.
Georgia Zoumpoulidou, Carlos Alvarez-Mendoza, Caterina Mancusi, Ritika-Mahmuda Ahmed, Milly Denman, Christopher D Steele, Maxime Tarabichi, Errin Roy, Lauren R Davies, Jiten Manji,[...]. Nat Commun 2021
3

Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer.
Judit Börcsök, Miklos Diossy, Zsofia Sztupinszki, Aurel Prosz, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, Dag R Stormoen, Helle Pappot, Istvan Csabai,[...]. Clin Cancer Res 2021
8

Simple prediction model for homologous recombination deficiency in breast cancers in adolescents and young adults.
Tomoko Watanabe, Takayuki Honda, Hirohiko Totsuka, Masayuki Yoshida, Maki Tanioka, Kouya Shiraishi, Yoko Shimada, Eri Arai, Mineko Ushiama, Kenji Tamura,[...]. Breast Cancer Res Treat 2020
1

TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer.
Julie Lecuelle, Romain Boidot, Hugo Mananet, Valentin Derangère, Juliette Albuisson, Vincent Goussot, Laurent Arnould, Zoé Tharin, Isabelle Ray Coquard, François Ghiringhelli,[...]. Cancers (Basel) 2021
1

Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine.
Peter Horak, Jonas Leichsenring, Hannah Goldschmid, Simon Kreutzfeldt, Daniel Kazdal, Veronica Teleanu, Volker Endris, Laura Gieldon, Michael Allgäuer, Anna-Lena Volckmar,[...]. Genes Chromosomes Cancer 2022
3

Discovery and validation of a transcriptional signature identifying homologous recombination-deficient breast, endometrial and ovarian cancers.
Guillaume Beinse, Pierre-Alexandre Just, Marie-Aude Le Frere Belda, Pierre Laurent-Puig, Sebastien Jacques, Meriem Koual, Simon Garinet, Karen Leroy, Nicolas Delanoy, Helene Blons,[...]. Br J Cancer 2022
0

Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types.
Jan Budczies, Klaus Kluck, Susanne Beck, Iordanis Ourailidis, Michael Allgäuer, Michael Menzel, Daniel Kazdal, Lukas Perkhofer, Alexander Kleger, Peter Schirmacher,[...]. J Pathol Clin Res 2022
0

Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification.
Benedetta Pellegrino, Andrea Herencia-Ropero, Alba Llop-Guevara, Flaminia Pedretti, Alejandro Moles-Fernández, Cristina Viaplana, Guillermo Villacampa, Marta Guzmán, Olga Rodríguez, Judit Grueso,[...]. Cancer Res 2022
2


Development of a Genomic Signatures-Based Predictor of Initial Platinum-Resistance in Advanced High-Grade Serous Ovarian Cancer Patients.
Yuan Li, Xiaolan Zhang, Yan Gao, Chunliang Shang, Bo Yu, Tongxia Wang, Junyan Su, Cuiyu Huang, Yu Wu, Hongyan Guo,[...]. Front Oncol 2021
4


Pan-cancer analysis reveals homologous recombination deficiency score as a predictive marker for immunotherapy responders.
Can Yang, Zijing Zhang, Xuemei Tang, Xinju Zhang, Yuming Chen, Tingting Hu, Huating Zhang, Ming Guan, Xiuming Zhang, Zhiyuan Wu. Hum Cell 2022
4

Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD).
E Rempel, K Kluck, S Beck, I Ourailidis, D Kazdal, O Neumann, A L Volckmar, M Kirchner, H Goldschmid, N Pfarr,[...]. NPJ Precis Oncol 2022
0

Biomarkers for Homologous Recombination Deficiency in Cancer.
Svenja Wagener-Ryczek, Sabine Merkelbach-Bruse, Janna Siemanowski. J Pers Med 2021
6